Detection of preclinical Parkinson’s disease along the olfactory trac(t)

  • H. W. Berendse
  • M. M. Ponsen
Part of the Journal of Neural Transmission. Supplementa book series (NEURALTRANS, volume 70)

Summary

The association of Parkinson’s disease (PD) with an impaired sense of smell was first reported about thirty years ago. Since then, it has become quite firmly established that olfactory dysfunction is one of the first and most prevalent clinical manifestations of this disorder. Recent data from an ongoing prospective study indicate that otherwise unexplained hyposmia in first degree relatives of patients with sporadic PD is associated with an increased risk of developing clinical PD of at least 13%. In particular, a combination of impaired olfactory function and reduced striatal [123I]β-CIT binding on a baseline SPECT scan appears to be a strong predictor of a subsequent diagnosis of PD. Pathological studies support these observations by demonstrating that the anterior olfactory structures may be one of the induction sites of PD pathology. Considering that there is a doubling rather than a loss of dopaminergic neurons in the olfactory bulb in PD patients, the pathophysiology of olfactory dysfunction in PD is far from being elucidated. Studying prodromal manifestations of PD, such as olfactory dysfunction, and their underlying pathophysiology may greatly contribute to the development of treatment strategies that focus on preclinical detection and slowing down disease progression.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berendse HW, Booij J, Francot CMJE, Bergmans PLM, Hijman R, Stoof JC, Wolters ECh (2001) Subclinical dopaminergic dysfunction in asymptomatic Parkinson’s disease patients’ relatives with a decreased sense of smell. Ann Neurol 50: 34–41PubMedCrossRefGoogle Scholar
  2. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24: 197–211PubMedCrossRefGoogle Scholar
  3. Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38: 1237–1244PubMedGoogle Scholar
  4. Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 62: 436–446PubMedCrossRefGoogle Scholar
  5. Huisman E, Uylings HBM, Hoogland PV (2004) A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Mov Disord 19: 687–692PubMedCrossRefGoogle Scholar
  6. Markopoulou K, Larsen KW, Wszolek EK, Denson MA, Lang AE, Peiffer RF, Wszolek ZK (1997) Olfactory dysfunction in familial parkinsonism. Neurology 49: 1262–1267PubMedGoogle Scholar
  7. Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 10: 283–287PubMedCrossRefGoogle Scholar
  8. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BLF, Wolters ECh, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Ann Neurol 56: 173–181PubMedCrossRefGoogle Scholar
  9. Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H (2004) Detection of presymptomatic Parkinson’s disease: Combining smell tests, transcranial sonography, and SPECT. Mov Disord 19: 1196–1202PubMedCrossRefGoogle Scholar
  10. Tissingh G, Berendse HW, Bergmans P, de Waard R, Drukarch B, Stoof JC, Wolters ECh (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 16: 41–46PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • H. W. Berendse
    • 1
  • M. M. Ponsen
    • 1
  1. 1.Department of NeurologyVU University Medical CenterAmsterdamThe Netherlands

Personalised recommendations